192 results on '"Win, Than"'
Search Results
2. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
3. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders
4. Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart disease
5. Postoperative opioid prescription patterns and new opioid refills following cardiac implantable electronic device procedures
6. Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removal
7. Predictors and outcomes of cardiac resynchronization therapy extended to the second generator
8. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
9. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
10. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices
11. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
12. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
13. 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion)
14. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope
15. Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: The PRIMERI Study
16. Letter to the Editor—Revisiting the prognostic role of SCN5A in Brugada syndrome
17. Hospital admission for syncope evaluation: Can we see the forest for the trees?
18. Regulation of the SK3 channel by microRNA-499—Potential role in atrial fibrillation
19. Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation
20. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients
21. HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection: Developed in Partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons
22. Hospital admission for syncope evaluation: Can we see the forest for the trees?
23. Autoantibodies and Cardiac Arrhythmias
24. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy
25. PO-642-05 TENSION HEMOTHORAX DUE TO APICAL LEAD PERFORATION TWO YEARS AFTER IMPLANTATION
26. PO-03-120 THE PROGNOSTIC OUTCOME OF ATYPICAL ATRIAL FLUTTER FOLLOWING A SINGLE ELECTROPHYSIOLOGY STUDY AND ABLATION
27. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy
28. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy
29. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?
30. Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart disease
31. Premature ventricular contraction ablation for treatment of heart failure
32. Premature ventricular contraction ablation for treatment of heart failure
33. B-PO01-025 A REAL-WORLD MULTICENTER EXPERIENCE OF ATRIOVENTRICULAR SYNCHRONOUS PACING WITH LEADLESS VENTRICULAR PACEMAKERS
34. B-PO02-035 ETIOLOGIES OF INADEQUATE ATRIOVENTRICULAR SYNCHRONOUS PACING WITH LEADLESS VENTRICULAR PACEMAKERS: A MULTICENTER EXPERIENCE
35. B-PO03-075 A VAGAL RESPONSE DURING CRYOBALLOON ABLATION INDICATES SUCCESSFUL PULMONARY VEIN ISOLATION AND LONG TERM FREEDOM FROM SYMPTOMIC ATRIAL FIBRILLATION
36. B-PO03-167 PREDICTING ARRHYTHMIC EVENT FOR ICD THERAPY IN BRUGADA SYNDROME: A PREDICTIVE SCORE FROM WORLDWIDE POOLED ANALYSIS
37. PO-642-05 TENSION HEMOTHORAX DUE TO APICAL LEAD PERFORATION TWO YEARS AFTER IMPLANTATION
38. Heart Rhythm Society Scientific Program Committee
39. Epidemiology of atrial fibrillation: A current perspective
40. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: The need for large-scale randomized trials
41. Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure
42. Epinephrine-induced T-wave notching in congenital long QT syndrome
43. Postoperative opioid prescription patterns and new opioid refills following cardiac implantable electronic device procedures
44. Incidence, patterns, and outcomes after transvenous cardiac device lead macrodislodgment: Insights from a population-based study
45. B-PO01-025 A REAL-WORLD MULTICENTER EXPERIENCE OF ATRIOVENTRICULAR SYNCHRONOUS PACING WITH LEADLESS VENTRICULAR PACEMAKERS
46. B-PO02-035 ETIOLOGIES OF INADEQUATE ATRIOVENTRICULAR SYNCHRONOUS PACING WITH LEADLESS VENTRICULAR PACEMAKERS: A MULTICENTER EXPERIENCE
47. B-PO03-167 PREDICTING ARRHYTHMIC EVENT FOR ICD THERAPY IN BRUGADA SYNDROME: A PREDICTIVE SCORE FROM WORLDWIDE POOLED ANALYSIS
48. Global remodeling of the ventricular interstitium in idiopathic myocardial fibrosis and sudden cardiac death
49. Incidence, patterns, and outcomes after transvenous cardiac device lead macrodislodgment: Insights from a population-based study
50. Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removal
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.